Home › Atopic Dermatitis (Eczema) › Nevada › Las Vegas
Atopic Dermatitis (Eczema) clinical trials in Las Vegas, NV
5 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in and around Las Vegas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
RecruitingObservational study
- Las Vegas Dermatology- Site Number : 8400002, Las Vegas
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Enveda Investigative Site, Las Vegas
Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
RecruitingObservational study
- Las Vegas Dermatology, Las Vegas
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
RecruitingPhase 3
- Las Vegas Dermatology /ID# 265801, Las Vegas
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
RecruitingObservational study
- Galderma Investigational Site 8848, Las Vegas
Atopic Dermatitis (Eczema) trials in other cities
- New York City, NY13 studies
- Washington, DC11 studies
- Los Angeles, CA11 studies
- San Diego, CA10 studies
- San Antonio, TX10 studies
- Miami, FL9 studies
- Birmingham, AL9 studies
- Troy, MI8 studies
- Huntington Beach, CA8 studies
- Dallas, TX8 studies
- Sacramento, CA8 studies
- Indianapolis, IN7 studies
Other studies in Las Vegas
- Obesity27 studies
- Overweight23 studies
- Type 2 Diabetes18 studies
- Non-Small Cell Lung Cancer13 studies
- Major Depressive Disorder13 studies
- Breast Cancer10 studies
- Alzheimer's Disease8 studies
- Prostate Cancer8 studies
- Acute Myeloid Leukemia8 studies
- Cancer (all types)8 studies
- Steatotic Liver Disease7 studies
- Endometrial Cancer7 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.